AFT Pharmaceuticals Limited provided earnings guidance for the year to 31 March 2023. Targeting an operating profit range for the year to 31 March 2023 of between $27 million and $32 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.09 NZD | +0.65% | -1.59% | -11.71% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.71% | 191M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals Limited Provides Earnings Guidance for the Year to 31 March 2023